According To Cutting Edge Information, Companies Now Outsource Less Of Clinical Development Budget Pharmaceutical companies across the industry have significantly cut outlays to outsourcing as a percentage of clinical development budgets, according to "Streamlining Clinical Trials," a new study by pharmaceutical business intelligence leader Cutting Edge Information. Comparison with earlier research by Cutting Edge Information in this arena reveals that reductions occur in every phase.
Source: www.medicalnewstoday.comRaptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation In Non-Alcoholic Steatohepatitis (NASH) Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), announced the initiation of patient dosing in a Phase 2a clinical trial, in collaboration with the University of California, San Diego ("UCSD"), to evaluate cysteamine bitartrate ("cysteamine") in adolescents diagnosed with Non-alcoholic Steatohepatitis ("NASH").
Source: www.medicalnewstoday.comFocus On Women: Advances In Breast Health Presented By Bon Secours St. Francis Health System On Tuesday, October 28, as part of Breast Cancer Awareness Month, physicians and
health experts from Bon Secours St. Francis
Health System will discuss the importance of detection, treatment, and management of breast disease. Participating in the discussion will be Gail Thomas, MD, a surgical oncologist with Carolina Surgical Associates, breast
health navigator, Kathy Koger, RN, BSN, and genetic consultant, Julie Eggert, PhD., ARPN-BC, AOCN.
Source: www.medicalnewstoday.comGeoVax's DNA And MVA Vaccines Shipped To HIV Vaccine Trials Network For Use In The Upcoming Phase 2a Trial GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced it has shipped both DNA and MVA components of its AIDS vaccine to the HIV Vaccine Trials Network (HVTN) pharmacy, for use in the upcoming Phase 2a human clinical trial. This Phase 2a study will involve 150 vaccinees and 75 placebo (control) participants.
Source: www.medicalnewstoday.comWomen's Contraceptive Perceptions And Realities Don't Match Up Women's feelings and behaviors concerning contraception are conflicted, yet many don't seek out methods that could better satisfy their needs, according to a new survey conducted on behalf of Schering-Plough by Harris Interactive®.
Source: www.medicalnewstoday.comSouth Africa In Grip Of Strangulation Spate Murder of women by strangulation is a serious problem in South Africa. Researchers writing in the open access journal BMC Public
Health compared four South African cities for the period 2001 to 2005, and report information about the prevalence and timing of attacks, and give details about the victims. Most cases of strangulation are committed by men against women, as it requires a large disparity in strength between attacker and victim.
Source: www.medicalnewstoday.comRuthenium In A Clinch Amines are needed for the production of pharmaceuticals, fine chemicals, agrochemicals, plastics, dyes, pigments, and additives. Most important are compounds with a terminal amino group (-NH2), known as primary amines. However, the selective synthesis of primary amines remains a challenge.
Source: www.medicalnewstoday.com
# posted by Network @ 10:00 AM
